Black Rock Inc. Olema Pharmaceuticals, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,999,518 shares of OLMA stock, worth $18.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,999,518
Previous 3,216,554
24.34%
Holding current value
$18.6 Million
Previous $36.4 Million
18.85%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding OLMA
# of Institutions
161Shares Held
69.2MCall Options Held
235KPut Options Held
1.3K-
Bain Capital Life Sciences Investors, LLC Boston, MA7.47MShares$34.8 Million11.76% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY7.3MShares$34 Million1.62% of portfolio
-
Bvf Inc San Francisco, CA5.72MShares$26.6 Million1.25% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.67MShares$17.1 Million0.05% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.44MShares$16 Million0.88% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $188M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...